Forte Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Forte Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2023.
  • Forte Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 21M shares, a 42.6% increase year-over-year.
  • Forte Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17.4M shares, a 24.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 21M +6.29M +42.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21M +6.25M +42.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 17.4M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 18.9M +4.69M +32.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 14.8M +1.16M +8.51% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 14.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 14.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 13.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.